Dai Yun, Rahmani Mohamed, Pei Xin-Yan, Khanna Payal, Han Song Iy, Mitchell Clint, Dent Paul, Grant Steven
Department of Medicine, Virginia Commonwealth University/Medical College of Virginia, Richmond VA, 23298, USA.
Blood. 2005 Feb 15;105(4):1706-16. doi: 10.1182/blood-2004-07-2767. Epub 2004 Oct 19.
Interactions between the Chk1 inhibitor UCN-01 and the farnesyltransferase inhibitor L744832 were examined in human leukemia cells. Combined exposure of U937 cells to subtoxic concentrations of UCN-01 and L744832 resulted in a dramatic increase in mitochondrial dysfunction, apoptosis, and loss of clonogenicity. Similar interactions were noted in other leukemia cells (HL-60, Raji, Jurkat) and primary acute myeloid leukemia (AML) blasts. Coadministration of L744832 blocked UCN-01-mediated phosphorylation of mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK), leading to down-regulation of phospho-cyclic adenosine monophosphate responsive element-binding protein (phospho-CREB) and -p90(RSK) and activation of p34(cdc2) and stress-activated protein kinase/ERK kinase/c-Jun N-terminal kinase (SEK/JNK). Combined treatment also resulted in pronounced reductions in levels of phospho-Akt, -glycogen synthase kinase-3 (-GSK-3), -p70(S6K), -mammalian target of rapamycin (-mTOR), -forkhead transcription factor (-FKHR), -caspase-9, and -Bad. Ectopic expression of Bcl-2 or Bcl-xL but not dominant-negative caspase-8 blocked UCN-01/L744832-mediated mitochondrial dysfunction and apoptosis but did not prevent activation of p34(cdc2) and JNK or inactivation of MEK/ERK and Akt. Enforced expression of myristoylated Akt but not constitutively active MEK significantly attenuated UCN-01/L744832-induced apoptosis. However, dual transfection with Akt and MEK resulted in further protection from UCN-01/L744832-mediated lethality. Finally, down-regulation of JNK1 by siRNA significantly reduced the lethality of the UCN-01/L744832 regimen. Together, these findings suggest that farnesyltransferase inhibitors interrupt the cytoprotective Akt and MAPK pathways while reciprocally activating SAPK/JNK in leukemia cells exposed to UCN-01 and, in so doing, dramatically increase mitochondria-dependent apoptosis.
在人白血病细胞中检测了Chk1抑制剂UCN - 01与法尼基转移酶抑制剂L744832之间的相互作用。将U937细胞联合暴露于亚毒性浓度的UCN - 01和L744832会导致线粒体功能障碍、细胞凋亡以及克隆形成能力丧失显著增加。在其他白血病细胞(HL - 60、Raji、Jurkat)和原发性急性髓系白血病(AML)原始细胞中也观察到了类似的相互作用。联合给予L744832可阻断UCN - 01介导的丝裂原活化蛋白激酶激酶/细胞外信号调节激酶(MEK/ERK)磷酸化,导致磷酸化环磷酸腺苷反应元件结合蛋白(磷酸化 - CREB)和 - p90(RSK)下调以及p34(cdc2)和应激激活蛋白激酶/ERK激酶/c - Jun氨基末端激酶(SEK/JNK)激活。联合治疗还导致磷酸化Akt、 - 糖原合酶激酶 - 3( - GSK - 3)、 - p70(S6K)、 - 雷帕霉素哺乳动物靶标( - mTOR)、 - 叉头转录因子( - FKHR)、 - 半胱天冬酶 - 9和 - Bad水平显著降低。Bcl - 2或Bcl - xL的异位表达而非显性负性半胱天冬酶 - 8可阻断UCN - 01/L744832介导的线粒体功能障碍和细胞凋亡,但不能阻止p34(cdc2)和JNK的激活或MEK/ERK和Akt的失活。肉豆蔻酰化Akt的强制表达而非组成型活性MEK可显著减轻UCN - 01/L744832诱导的细胞凋亡。然而,Akt和MEK的双重转染可进一步保护细胞免受UCN - 01/L744832介导的致死作用。最后,通过小干扰RNA(siRNA)下调JNK1可显著降低UCN - 01/L744832方案的致死率。总之,这些发现表明,在暴露于UCN - 01的白血病细胞中,法尼基转移酶抑制剂会中断细胞保护性Akt和MAPK途径,同时相互激活SAPK/JNK,从而显著增加线粒体依赖性细胞凋亡。